Published 2 days ago • loading... • Updated 2 days ago

Immunic Announces Closing of Oversubscribed Private Placement Financing

Immunic, Inc. announced it closed a private placement in its press materials, with the offering oversubscribed, according to the company.
Seeking runway for R&D, Immunic executed the private placement to support operations and development programs, the company said.
Investor demand outpaced the original offering, leaving the private placement oversubscribed and structured as a non‑public securities sale to investors, the company said.
With the financing closed, Immunic secures capital to support operations, affecting shareholders, employees, and ongoing development programs, the company said.
Announced by the company, the placement is a timely corporate‑financing update that positions Immunic to advance its development programs and near‑term plans.

Insights by Ground AI